ASAna Luiza Corrêa Silva

Ana Luiza Corrêa Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Luiza Corrêa Silva has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Potenciais interações medicamentosas graves em pacientes com doença renal crônica não dialítica: uma frequência preocupante

    by Ana Luiza Corrêa Silva, João Pedro Vasconcelos Paolinelli, Paula Camilo Contaiffer, Karla Amaral Nogueira Quadros, Flávio Augusto de Morais, André Oliveira Baldoni, Alba Otoni

    Objective: to evaluate potential severe and moderate drug interactions in patients with chronic kidney disease (CKD) not on dialysis and using polypharmacy. Methodology: cross-sectional study carried out in a city in the center-west of Minas Gerais/Brazil. The population consisted of patients with non-dialysis kidney disease treated at the municipal nephrology clinic. Descriptive analysis was used to characterize the sociodemographic, clinical, and laboratory profile of the population. Bivariate logistic regression analysis was applied to determine factors associated with potential drug interactions. Variables with p-value < 0.20 were taken to the multivariate model. Results: Of the total of 75 participants, most were female, elderly and white. Among them, 60% (45/75) were in stage 3A and 3B of kidney disease. No significant association was found between the use of polypharmacy and Estimated Glomerular Filtration Rate (p Conclusions: high rates of moderate drug interactions were found, in addition to the presence of severe interactions. The association of multiple drugs in pharmacotherapy, especially for elderly patients with kidney disease, is often unavoidable and, therefore, deserves special attention not only from prescribing professionals but also from the entire team in order to safeguard the safety of these patients, avoiding events adverse events related to MIs.